Metabolism - Clinical and Experimental
Volume 47, Issue 9 , Pages 1042-1047, September 1998

The effect of glucose and glucagon-like peptide-1 stimulation on insulin release in the perfused pancreas in a non—insulin-dependent diabetes mellitus animal model

  • Hua-Qiong Shen

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Hua-Qiong Shen, MD, PhD, Department of Medicine, Division of Endocrinology and Metabolism, Indiana University Medical Center, 541 N Clinical Dr, CL 459, Indianapolis, IN 46202-5111.
  • ,
  • Mark D. Roth
  • ,
  • Richard G. Peterson

Department of Anatomy, Indiana Univeristy School of Medicine, Indianapolis, IN, USA

Received 4 April 1997; accepted 19 February 1998.

Abstract 

This study was designed to investigate the effect of glucogon-like peptide-1 (GLP-1) on pancreatic β-cell function in normal, Zucker diabetic fatty (ZDF) rats, a model for non—insulin-dependent diabetes mellitus (NIDDM or type II diabetes) and their heterozygous siblings. Pancreas perfusion and enzyme-linked immunosorbent assay (ELISA) were used to detect the changes in insulin release under fasting and hyperglycemic conditions and following stimulation with GLP-1. Animals from the ZDF/Gmi-fa rats (ZDF) were grouped according to age, sex, and phenotype (obese or lean), and compared with LA lean rats. Glucose stimulation (10 mmol/L) in obese rats showed repressed response is insulin release. Glucose plus GLP-1 stimulation caused increased insulin release in all groups. The degree of this response differed between groups: lean > obese; young > adult; female > male. The LA lean control group was most sensitive, while the ZDF overtly diabetic group had the lowest response. In addition, the pulsatile pattern of insulin secretion was suppressed in ZDF rats, especially in obese groups. These results support the hypothesis that GLP-1 can effectively stimulate insulin secretion. Insulin release was defective in ZDF obese rats and could be partially restored with GLP-1. ZDF lean rats also showed suppression of β-cell function and there was a difference in β-cell function related to sex in ZDF strain. This study documents the efficacy of GLP-1 to stimulate insulin release and contributes to our understanding of the pathophysiological mechanisms underlying NIDDM.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by fellowship from Indiana University and by Genetic Models Inc (Indianapolis, IN).

PII: S0026-0495(98)90275-X

Metabolism - Clinical and Experimental
Volume 47, Issue 9 , Pages 1042-1047, September 1998